Updated:
GlaxoSmithKline US Pension Fund
The GlaxoSmithKline US Pension Fund operates as the US defined contribution plan for GSK plc, the British pharmaceutical firm. In 2021, the plan's Cash Balance...
GlaxoSmithKline US Pension Fund
The GlaxoSmithKline US Pension Fund operates as the US defined contribution plan for GSK plc, the British pharmaceutical firm. In 2021, the plan's Cash Balance Pension Plan was amended to freeze eligibility and company contributions for new participants. Existing accounts continue to earn interest, but no fresh company credits are added. The plan maintains an alternatives portfolio that spans private equity, venture capital, real assets, and credit strategies. The fund sources its investments through direct commitments and fund partnerships. While specific holdings are not publicly disclosed, the fund is a long-standing participant in institutional private markets and lists membership in the Institutional Limited Partners Association. The fund is administered by the US Reward and Benefit Director, based in Philadelphia. Its alternative asset operations are centered in Pennsylvania. The plan does not publicly disclose total assets, personnel count, or recent deployment figures. The plan's structural distinction lies in its frozen status — a corporate pension that continues to steward legacy pools of retirement capital while no longer growing through employer contributions, making asset-liability management and capital preservation its dominant posture.
General information
Firm type
Pension Fund
Location
Region
North America
Country
United States
City
Philadelphia
Corporate office
Philadelphia, NC, United States
Principals
US Reward and Benefit Director
Plan Administrator
Sector focus
Frequently asked questions
Who administers the GlaxoSmithKline US Pension Fund?
The plan is administered by the US Reward and Benefit Director at GSK, who serves as Plan Administrator and key decision-maker for the fund's operations and investments.
How did the 2021 plan amendment change the pension's structure?
The Cash Balance Pension Plan component was amended to freeze eligibility and company credits for new participants and future contributions. Existing accounts continue to grow with credited interest, but the plan no longer receives fresh employer contributions for new participants.
What is the fund's relationship with GSK plc?
GSK plc is the plan sponsor and parent company. The pension fund provides retirement, disability, and death benefits exclusively to eligible US employees of GSK.
Does the fund invest in alternative assets?
Yes. The fund maintains a dedicated alternative asset portfolio that includes private equity, venture capital, real assets, and credit strategies, operated out of Philadelphia.
Is the plan a single employer defined benefit scheme or a defined contribution plan?
It is structured as a defined contribution plan, providing retirement benefits to US-based GSK employees rather than operating as a traditional defined benefit pension scheme.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on pension funds?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: